Literature DB >> 31388745

Revisiting the physiology of nausea and vomiting-challenging the paradigm.

Rita J Wickham1.   

Abstract

PURPOSE: The predominant neurotransmitters and receptors for acute and delayed chemotherapy-induced nausea and vomiting (CINV) are represented in the current paradigm, which reflects successful control of emesis. However, control of nausea (N) lags behind management of vomiting (V). This review aims to re-examine and incorporate new information about the mechanisms of V and N.
METHODS: The initial literature search focused on CINV. Keywords in articles led to subsequent discovery of publications focused on N&V in other medical and scientific fields (e.g., gastroenterology, neurology, cannabinoid science, neuropharmacology, and motion sickness). Using keywords to identify other sources continued until no further recent, meaningful publications were found.
RESULTS: More than 86% of references were from recent non-oncology journals and books, suggesting there are many areas for cross-fertilization research into mechanisms and management of N&V-particularly of N, which involves overlapping and dissimilar CNS areas from V. Information from cited articles was incorporated into visual representation of N&V, which is certainly not exhaustive but supports highly complex processes in the stomach and gut, the vagus nerve and spinal cord neurons, the nucleus tractus solitarii, and the anterior insular cortex and anterior cingulate cortex with input from the amygdala.
CONCLUSIONS: These data support the idea that mechanisms for N, whatever the cause, must be highly similar. Continued research into nausea, including patient-reported evaluation and outcomes, is important; interventions for nausea could be considered adjuvants to current standard of care antiemetics and be individualized, depending on patient-reported efficacy and adverse effects and preferences.

Entities:  

Keywords:  Gut-brain axis; Insular cortex; Interoception; Nausea; Vomiting

Mesh:

Substances:

Year:  2019        PMID: 31388745     DOI: 10.1007/s00520-019-05012-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  50 in total

1.  Chemotherapy-Induced Nausea and Vomiting: Time for More Emphasis on Nausea?

Authors:  Terry L Ng; Brian Hutton; Mark Clemons
Journal:  Oncologist       Date:  2015-05-06

2.  The brain circuitry underlying the temporal evolution of nausea in humans.

Authors:  Vitaly Napadow; James D Sheehan; Jieun Kim; Lauren T Lacount; Kyungmo Park; Ted J Kaptchuk; Bruce R Rosen; Braden Kuo
Journal:  Cereb Cortex       Date:  2012-04-02       Impact factor: 5.357

3.  Nausea in advanced cancer: relationships between intensity, burden, and the need for help.

Authors:  Signe Ladegaard Harder; Mogens Groenvold; Jørn Herrstedt; Anna Thit Johnsen
Journal:  Support Care Cancer       Date:  2018-06-26       Impact factor: 3.603

Review 4.  The medical implications of gastrointestinal vagal afferent pathways in nausea and vomiting.

Authors:  Charles C Horn
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 5.  What is nausea? A historical analysis of changing views.

Authors:  Carey D Balaban; Bill J Yates
Journal:  Auton Neurosci       Date:  2016-07-16       Impact factor: 3.145

6.  Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis.

Authors:  Heidi S Donovan; Teresa L Hagan; Grace B Campbell; Michelle M Boisen; Leah M Rosenblum; Robert P Edwards; Dana H Bovbjerg; Charles C Horn
Journal:  Support Care Cancer       Date:  2016-01-08       Impact factor: 3.603

7.  Gastric dysrhythmias: a potential objective measure of nausea.

Authors:  Kenneth L Koch
Journal:  Exp Brain Res       Date:  2014-06-12       Impact factor: 1.972

8.  What occurs in the other 20% of cancer patients with chemotherapy-induced nausea and vomiting (CINV)? A single-institution qualitative study.

Authors:  Daniel S Childs; Sherry Looker; Jennifer Le-Rademacher; Jennifer L Ridgeway; Carmen Radecki Breitkopf; Aminah Jatoi
Journal:  Support Care Cancer       Date:  2018-06-25       Impact factor: 3.603

Review 9.  Ghrelin.

Authors:  T D Müller; R Nogueiras; M L Andermann; Z B Andrews; S D Anker; J Argente; R L Batterham; S C Benoit; C Y Bowers; F Broglio; F F Casanueva; D D'Alessio; I Depoortere; A Geliebter; E Ghigo; P A Cole; M Cowley; D E Cummings; A Dagher; S Diano; S L Dickson; C Diéguez; R Granata; H J Grill; K Grove; K M Habegger; K Heppner; M L Heiman; L Holsen; B Holst; A Inui; J O Jansson; H Kirchner; M Korbonits; B Laferrère; C W LeRoux; M Lopez; S Morin; M Nakazato; R Nass; D Perez-Tilve; P T Pfluger; T W Schwartz; R J Seeley; M Sleeman; Y Sun; L Sussel; J Tong; M O Thorner; A J van der Lely; L H T van der Ploeg; J M Zigman; M Kojima; K Kangawa; R G Smith; T Horvath; M H Tschöp
Journal:  Mol Metab       Date:  2015-03-21       Impact factor: 7.422

Review 10.  A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.

Authors:  Gareth J Sanger; Paul L R Andrews
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

View more
  9 in total

Review 1.  Metagenomics and chemotherapy-induced nausea: A roadmap for future research.

Authors:  Sylvia L Crowder; Aasha I Hoogland; Taylor L Welniak; Elizabeth A LaFranchise; Kristen M Carpenter; Daneng Li; Daniel M Rotroff; Arshiya Mariam; Christine M Pierce; Stacy M Fischer; Anita Y Kinney; Thi Dong-Binh Tran; Farzaneh Rastegari; Donna L Berry; Martine Extermann; Richard D Kim; Danielle B Tometich; Jane C Figueiredo; Jameel Muzaffar; Shahla Bari; Kea Turner; George M Weinstock; Heather S L Jim
Journal:  Cancer       Date:  2021-10-13       Impact factor: 6.860

Review 2.  Mitigating acute chemotherapy-associated adverse events in patients with cancer.

Authors:  Nicole M Kuderer; Aakash Desai; Maryam B Lustberg; Gary H Lyman
Journal:  Nat Rev Clin Oncol       Date:  2022-10-11       Impact factor: 65.011

Review 3.  Nausea and Vomiting Not Related to Cancer Therapy: Intractable Problem or Clinical Challenge?

Authors:  Rita J Wickham
Journal:  J Adv Pract Oncol       Date:  2020-07-01

4.  Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis.

Authors:  Haohao Lu; Chuansheng Zheng; Bin Liang; Bin Xiong
Journal:  BMC Cancer       Date:  2021-05-07       Impact factor: 4.430

Review 5.  The Clinical Observation of Acupuncture Combined With Antiemetic Drugs in the Prevention and Treatment of CINV in Breast Cancer Patients.

Authors:  Fanming Kong; Ziwei Wang; Na Wang; Lu Zhao; Qingyun Mei; Yongchao Yu; Dou Zhang; Xiaojiang Li; Yingjie Jia
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

6.  Paradigm and Path of Released Prisoners' Rights of Rehabilitation from the Perspective of Social Governance.

Authors:  Meifeng Ma
Journal:  J Environ Public Health       Date:  2022-09-19

Review 7.  Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.

Authors:  Weixia Zhong; Omar Shahbaz; Garrett Teskey; Abrianna Beever; Nala Kachour; Vishwanath Venketaraman; Nissar A Darmani
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

8.  Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial.

Authors:  Maurice J D L van der Vorst; Elisa C Toffoli; Marlien Beusink; Myra E van Linde; Theo van Voorthuizen; Saskia Brouwer; Annette A van Zweeden; Suzan Vrijaldenhoven; Johan C Berends; Johannes Berkhof; Henk M W Verheul
Journal:  Oncologist       Date:  2020-08-21

Review 9.  Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Maryam Omran; Elizabeth K Belcher; Nimish A Mohile; Shelli R Kesler; Michelle C Janelsins; Andrea G Hohmann; Ian R Kleckner
Journal:  Front Mol Biosci       Date:  2021-06-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.